Early Detection of COVID-19 Using Breath Analysis - Feasibility Study

Launched by SCENTECH MEDICAL TECHNOLOGIES LTD · Oct 23, 2020

Keywords

ClinConnect Summary

An interventional diagnostic prospective study study with risks and minimal constraints.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Hospitalized group:
• • Age 18 to 75 years at the time of consent
• • Positive results for SARS-CoV-2
• • Capable of understanding written and/or spoken language
• • Able to provide informed consent
• • Was not treated with Anti-viral drugs
• • Not a pregnant woman
• Healthy group:
• • Healthy volunteers
• • Age 18 to 75 years at the time of consent
• • No history of COVID-19
• • Capable of understanding written and/or spoken language
• • Able to provide informed consent
• • Was not treated with Anti-viral drugs
• • Not a pregnant woman
• • Sexes Eligible for Study: All
• Exclusion Criteria:
• Hospitalized group:
• • Age under 18 years old
• • (Anticipated) inability to complete breath sampling procedure due to e.g. hyper- or hypoventilation, respiratory failure or claustrophobia when wearing the sampling mask
• • Persons under guardianship or deprived of liberty
• • Patients with the following diseases: Cancer, Asthma, Chronic Respiratory Disease
• Healthy group:
• • Age under 18 years old
• • History of COVID-19
• • Persons under guardianship or deprived of liberty
• • Subjects with the following diseases: Cancer, Asthma, Chronic Respiratory Disease